Lorazepam Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lorazepam Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on May 3, 2018. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-1985-30
- Dosage Form
- Injection
- Presentation
- Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)
- Initial Posting
- May 3, 2018
Reason
Demand increase for the drug